Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ozonated ointments may improve surgical scar quality

NCT ID NCT07678372

Symptom relief Sponsor: Laboratorios Ozoaqua Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 14, 2026 · Updated 7 times

Summary

This study tests whether using ozonated soap and oil after open abdominal surgery leads to better scar quality than standard care alone. About 144 adults having scheduled abdominal surgery will be randomly assigned to either add the ozonated products to their usual wound care or receive standard care only. A blinded evaluator will assess scar appearance at 3 months using a validated scale, and patients will also report their own scar experience.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ozonated oil soap and ozonated oil
What this could lead to
If it works, this could offer a simple, affordable way to improve scar appearance and reduce discomfort after abdominal surgery.
What could go wrong
This is a small, early-stage study. The improvement may be small or no better than standard care, and some people may have skin reactions to the ozonated products.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 144 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * Scheduled open abdominal surgery * Primary wound closure * Assessable linear abdominal scar * Signed informed consent * Ability to complete 3-month follow-up Exclusion Criteria: * Known allergy to treatment components * Active infection or significant dehiscence in the immediate postoperative period * Planned use of specific scar treatments -silicone products, laser therapy, local corticosteroids- except as clinical rescue treatment * Inability to complete follow-up * Participation in another study that may interfere with wound healing

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abdominal surgery Post-surgical abdominal scar after open abdominal surgery Scar improvement Wound healing

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clínica Universidad de Navarra

    Pamplona, Navarre, 31008, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.